Innovative Technologies for amorphous solid dispersions

More and more poorly water-soluble or even water-insoluble drug candidates show up in pharmaceutical development. Achieving a good bioavailability and efficacy requires technical platforms and processes. Solid dispersions and amorphous solid dispersions are well established and proven approaches how to overcome the API solubility issue. Glatt’s technology platforms are highly efficient tools providing excellent quality and economic efficacy.

Learn more about the innovative solutions f in this webcast held by Dr. Norbert Pöllinger, Head of Technology Development at Glatt. Pharmaceutical Services

Date: 13.Mai.2020
Time: 03:00 PM

Click to get back to the Webcast Overview: